Brief: Rapt Therapeutics Q4 Net Income USD -53.249 Million
Mar 06 (Reuters) - Rapt Therapeutics Q4 operating income USD -54.465 million. Q4 basic EPS USD -1.14 Q4 operating expenses USD 54.465 million
Mar 06 (Reuters) - Rapt Therapeutics Q4 operating income USD -54.465 million. Q4 basic EPS USD -1.14 Q4 operating expenses USD 54.465 million